The future of congress – how pharma needs tailored approach

An EPG Health study in October 2021 – The Gaps between HCP Demand and Pharma Supply of Medical Information, highlighted that 78% of HCPs consider in-person congress and symposia to be important for learning with 70% also considering hybrid events as important. However, only 55% felt virtual events offered the same value for learning as in-person events.

A recent article in PMLiVE emphasised the opportunities that virtual and hybrid congresses will bring to pharma in years to come. The American Society of Clinical Oncology (ASCO) annual meeting in 2021, for example, still attracted nearly 33,000 attendees over its three online days, featuring 4,500 abstracts and 2,000 oral and poster presentations – approximately 75% of pre-pandemic figures. But the article also recommends that online and on-demand content needs to have engagement triggers and behavioural hooks to compensate for the lack of face-to-face contact.

With demand for in-person, fully virtual and hybrid events high and expected to remain so, the hybrid approach needs to ensure it can cater for the different audience requirements, whilst at the same time, continuing to deliver quality information. The hybrid format will no doubt help to attract a wider audience whilst also providing the added value of an in-person event. This is a win-win for congress organisers, however, it is twice the work.

Tangent90 delivers tailored content sharing solutions. We will work together with your agency to provide the technology to enable the provision of content that your agency can leverage to enhance your congress presence. Our Resource Centre solution takes away most of the additional effort to make event content available, enabling you to collect and distribute all your congress literature and assets – allowing you to share digital scientific content, such as ePrints, track usage and helps build your consent database for subsequent follow-up post-event. Working together, we can ensure your booth optimises every opportunity to deliver your desired ROI.

To find out more about how Tangent90 can support your congress engagement requirements, please contact us at

Related news


Seeing the Value of Scientific Content

In Pharmaceutical Commerce magazine, Tangent90 CEO Jan van den Burg discusses the value that HCPs place on scientific content and highlights the opportunity that pharma should be taking now.


Need to scale up fast? Ready-made content can help

Veeva recently published an eBook which discusses the best practice approach for supporting emerging pharma to launch and scale content faster. It focuses on how digital communications have allowed field teams to spend more quality time with HCPs. What can pharma’s brand teams do to support the increase needed?

Using next best action to inform your engagement strategy

We have been inundated with discussions about big data. Information that can help inform decision making is an output of nearly every phase in life sciences. The industry, with the increased use of digital channels, has been able to collect more data but is this being used to optimise their HCP engagement strategies?

Scroll to Top

Book A Demo

We use cookies to improve your experience on our website. By browsing this website, you agree to our use of cookies.